Fred A Middleton
CIK 1267959 · last filed 2026-06-29
Fred A Middleton is a corporate insider who has filed 129 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing shows the insider bought $200.0K of CALC on Jun 29, 2026. Across all open-market trades the lifetime net is −$73.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions. 14 SEC filings were submitted jointly with Pacira BioSciences, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.73M
10
129
-$73.53M
Filer Profile
SAN MATEO, CA 94402-1708
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Director | 196,652 | $1.98 | $389.4K | $2.77M | 9 | 2026-06-29 |
| CHIMERIX INC (CMRX) Delisted | Director | 0 | $8.54 | $0 | $464.2K | 20 | 2025-04-21 |
| CalciMedica, Inc. (SCPH) Delisted | Director | 39,170 | $5.67 | $222.1K | $404.0K | 2 | 2024-11-05 |
| CalciMedica, Inc. (GRAY) Delisted | Director | 17,682 | $5.50 | $97.3K | $0 | 1 | 2023-03-22 |
| ENDOCYTE INC (ECYT) Delisted | Director | 0 | — | — | $5.32M | 16 | 2018-12-21 |
| STXS | Director | 343,244 | $1.29 | $442.8K | $5.97M | 50 | 2018-03-05 |
| Stereotaxis, Inc. (STXS.R) Delisted | Director | — | — | — | $0 | 4 | 2013-11-22 |
| PCRX | Director | 70,399 | $25.36 | $1.79M | -$61.29M | 10 | 2013-06-25 |
| BEAT | Director | 279,237 | $0.41 | $113.5K | -$27.16M | 11 | 2010-05-11 |
| MMRGlobal, Inc. (FVRL) Delisted | Director | 116,678 | — | — | $0 | 2 | 2007-11-06 |
Recent Filings
129 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | CALC | Buy (P) | +248,972 | $200.0K | EDGAR |
| 2025-06-26 | CALC | Grant (A) | — | $0 | EDGAR |
| 2025-04-21 | CHIMERIX INC (CMRX) Delisted | Disp (D) | −3,615,477 | -$30.91M | EDGAR |
| 2024-12-06 | CALC | Buy (P) | +4,800 | $12.7K | EDGAR |
| 2024-11-05 | CalciMedica, Inc. (SCPH) Delisted | Buy (P) | +107,744 | $404.0K | EDGAR |
| 2024-10-30 | CHIMERIX INC (CMRX) Delisted | Gift (G) | −60,000 | $0 | EDGAR |
| 2024-08-28 | CalciMedica, Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-22 | CALC | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | CALC | Buy (P) | +679,384 | $2.52M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.